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a b s t r a c t
Objectives: Little is known about the risk proﬁle and in-hospital prognosis of elderly patients
presenting for ST-elevation myocardial infarction (STEMI) in Tunisia. We sought to deter-
mine in-hospital prognosis of elderly patients with STEMI in a Tunisian center.
Methods: The study was carried out on a retrospective registry enrolling 1403 patients
presenting with STEMI in a Tunisian center between January 1998 and January 2013. Patients
≥75 years old were considered elderly. Risk factors and in-hospital prognosis were compared
between elderly and younger patients, and then predictive factors of in-hospital death were
determined in elderly patients.
Results: Out of the overall population, 211 (15%) were part of the elderly group. Compared to
younger patients, elderly patients were more likely to have arterial hypertension but less
likely to be smokers and obese. Thrombolysis was signiﬁcantly less utilized in the elderly
group (22.3% vs. 36.6% in the younger group, p < 0.001), whereas the use primary percuta-
neous coronary intervention was comparable between the two sub-groups (24.2% vs. 28.8%,
p = 0.17). The incidence of in-hospital complications was higher in the elderly group, and so
was the in-hospital mortality rate (14.2% vs. 8.1%, p = 0.005). Heart failure on-admission,
renal failure on-admission, and inotropic agents use were independently associated to in-
hospital death in the elderly group.
Conclusions: In the Tunisian context, elderly patients presenting with STEMI have higher
prevalence of risk factors and a worse in-hospital course in comparison to younger patients.
Clinical presentation on-admission has a strong impact on in-hospital prognosis.
# 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Coronary artery disease (CAD) and acute coronary syndromes
(ACS) are a leading cause of death all around the globe. The
introduction of new pharmacological therapeutics along with
a steady reduction in coronary revascularization delays
throughout the last two decades has led to substantial
improvements in both short- and long-term prognoses.1–3 In
Western countries, where efﬁcient primary percutaneous
coronary intervention (pPCI) programs have been implemen-
ted, in-hospital mortality in patients presenting with
ST-segment elevation myocardial infarction (STEMI) has
decreased in a striking manner and throughout all age
categories.1 On the other hand, in developing countries, and
especially with the progressive adoption of westernized
lifestyles and the increase of life expectancy, CAD is more
frequently encountered in older age groups and patients
presenting with STEMI in healthcare structures have a
changing epidemiology and outcomes over time. Published
data from Middle East and North Africa addressing the in-
hospital prognosis of STEMI speciﬁcally in the elderly are
scarce. Available data put the emphasis on the changing risk
proﬁle in this region of the world and often seek to compare
patients' characteristics and STEMI prognosis with that in
Western series in a general manner.4,5 Studies from North
African countries addressing the speciﬁc issue of CAD in the
elderly are nearly absent.
Therefore in this study, we sought to determine in-hospital
outcomes for elderly patients presenting with STEMI in a
Tunisian center and to study factors related to in-hospital
death in this population.
2. Methods
2.1. Study population and design
The analyses were performed on data from the STEMI registry
of the cardiology B department of Fattouma Bourguiba
University Hospital (Monastir, Tunisia). The registry includes
retrospectively all consecutive patients presenting to our
center via the emergency department or the SAMU (Service
d'Aide Médicale Urgente for Emergency Medical Service) and for
whom the ﬁnal diagnosis established was STEMI, regardless to
the therapeutic strategy implemented. The diagnosis of STEMI
was established in the presence of 2 mm (in precordial leads)
or 1 mm (in frontal leads) ST-segment elevation in two
adjacent leads or a new left bundle branch block concurrently
to a typical prolonged chest pain (>20 min). The registry is
updated for new patients and outcomes in a yearly fashion.
The present study included patients enrolled during the
period between January 1998 and January 2013. The overall
study population was divided into two groups according to age;
patients, who were ≥75 years old, were considered elderly.
Demographic features, cardiovascular risk factors, clinical
presentation, and in-hospital course were compared between
the two study groups. Given the relatively small number of
patients in the two age sub-groups, temporal trends for
reperfusion therapy and in-hospital mortality were reportedfor the four four-year sub-periods of the study (1998–2001, 2002–
2005, 2006–2009 and 2010–2013). Anemia was deﬁned as a
hemoglobin rate <12 g/dL in men and <11 g/dL in women. Heart
failure on-admission was deﬁned as a Killip class II or III upon
presentation. Renal failure on-admission was deﬁned as a
creatinine clearance <45 mL/min using the Modiﬁcation of Diet
in Renal Disease (MDRD) formula in patients not previously
known to suffer from chronic kidney disease (CKD); in patients
known to have CKD, renal failure on-admission was deﬁned as
an increase of ≥30% of baseline serum creatinine rate. Patients
on dialysis were excluded. All patients received 100 IU per kg of
weight of unfractionated heparin upon diagnosis, 250 mg
aspirin and a loading dose of 300 or 600 mg clopidogrel
according to the reperfusion strategy chosen (thrombolysis or
pPCI). If no reperfusion modality was decided, patients received
only 75 mg clopidogrel upon presentation. Medications at
discharge included aspirin for life, clopidogrel for 3–12 months
in addition to statins, beta-blockers, and angiotensin-convert-
ing enzyme (ACE) inhibitors, when indicated. Spontaneous
ﬁbrinolysis was deﬁned as complete ST-segment resolution
concomitant to the disappearance of any chest discomfort in
the few minutes upon presentation and before the initiation of
any reperfusion therapy (thrombolysis or pPCI). Relevant factors
associated to in-hospital death in the elderly group were studied
in univariate analysis. Multivariate analysis was performed to
determine factors that were independently associated to in-
hospital death in the elderly group.
2.2. Statistical analysis
Categorical variables are presented in absolute values and
proportions. Continuous variables are presented as mean
standard deviation as appropriate. When indicated, the Student
t-test was used to compare means. The Pearson chi-square test
was used to compare proportions between the two subgroups of
the study population as a whole and in each study sub-period. It
was also used to determine factors in the elderly group that were
associated with in-hospital death in univariate analysis.
Multivariate analysis was performed using binary logistic
regression for variables that were signiﬁcantly associated to
in-hospital death in univariate analysis. The Hosmer and
Lemeshow test was applied to discard variables that were not
signiﬁcantly associated with in-hospital death in the interme-
diate analysis. Multivariable adjusted odds ratio (OR) with
accompanying 95% conﬁdence intervals were reported. A
p value of <0.05 was considered statistically signiﬁcant.
Statistical analysis was performed using the Statistical Package
for the Social Sciences (SPSS) 17.0 version.
3. Results
A total of 1403 patients were enrolled during the study period.
Out of the overall study population, 1155 (82.3%) were male,
421 (30%) had arterial hypertension and 495 (35.3%) a history of
diabetes mellitus. Two hundred eleven (15%) patients were
part of the elderly group. Clinical characteristics and cardio-
vascular risk factors of the patients are presented in Table 1. In
summary, compared to younger patients, patients in the
elderly group were less frequently male with a lower
Table 1 – Patients characteristics in the overall population and according to age category.
Population (n = 1403) Age < 75 (n = 1192) Age ≥ 75 (n = 211) p
Male gender 1155 (82.3%) 1011 (84.8%) 144 (68.2%) <0.001
Hypertension 421 (30%) 329 (27.6%) 92 (43.6%) <0.001
Diabetes mellitus 495 (35.2%) 431 (36.2%) 64 (30.3%) 0.103
Tobacco smoking 938 (66.8%) 842 (70.6%) 96 (45.5%) <0.001
Obesity 178 (12.6%) 168 (14.1%) 10 (4.8%) <0.001
History of heart failure 33 (2.3%) 25 (2.1%) 8 (3.8%) 0.134
History of PCI or CABG 55 (3.9%) 51 (4.3%) 4 (1.9%) 0.1
Anemia 216 (15.4%) 174 (16.1%) 42 (22.5%) 0.033
Anterior localization 647 (46.1%) 553 (50.7%) 94 (49.7%) 0.8
CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.
Table 2 – Management of patients and in-hospital prognosis according to age category.
Population (n = 1403) Age < 75 (n = 1192) Age ≥ 75 (n = 211) p
Spontaneous ﬁbrinolysis 140 (9.9%) 125 (10.5%) 15 (7.1%) 0.131
Conservative medical therapy 435 (31%) 344 (28.9%) 91 (43.1%) <0.001
Thrombolysis 483 (34.4%) 436 (36.6%) 47 (22.3%) <0.001
Symptoms to thrombolysis delay (h) 3.79  4.03 4.2  4.24 3.68  2.08 0.402
pPCI 394 (28%) 343 (28.8%) 51 (24.2%) 0.17
Symptoms to pPCI delay (h) 4.88  4.23 4.9  4.17 5.07  4.57 0.811
Heart failure on-admission 306 (21.8%) 243 (20.4%) 63 (29.9%) 0.002
Renal failure on-admission 115 (8.2%) 83 (7%) 32 (15.2%) <0.001
Hyperglycemia on-admission 468 (33.3%) 401 (40.1%) 67 (36%) 0.291
Cardiogenic shock 33 (2.4%) 21 (1.8%) 12 (5.7%) 0.001
New onset atrial ﬁbrillation 90 (6.4%) 65 (5.5%) 25 (11.8%) <0.001
Atrioventricular block 133 (9.4%) 99 (8.3%) 34 (16.1%) 0.002
Hemorrhage 38 (2.7%) 30 (2.5%) 8 (3.9%) 0.265
Inotropic agents use 206 (14.6%) 164 (13.8%) 42 (19.9%) 0.02
CCU length of stay (days) 4.74  3.5 4.7  3.46 4.98  4 0.332
In-hospital death 127 (9%) 97 (8.1%) 30 (14.2%) 0.005
CCU, coronary care unit; pPCI, primary percutaneous intervention.
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elderly patients were more frequently hypertensive and
presented more frequently with heart failure and renal failure
on-admission. New-onset atrial ﬁbrillation and atrioventricu-
lar block in the hospital course were more frequently
encountered in the elderly group. Concerning therapeutics
implemented (Table 2), thrombolysis in the acute phase of
myocardial infarction was the reperfusion option in 22.3% of
the cases in the elderly group compared to 36.6% in the
younger group (p < 0.001). Conservative medical therapy withTable 3 – Temporal trends in reperfusion therapies used and in
the study period. Percentages express rates in the correspond
1998–2001 (n = 281) 200
pPCI Young (334) 19 (8.1%) 
Elderly (51) 5 (11.1%)
Thrombolysis Young (436) 107 (45.3%) 
Elderly (47) 12 (26.7%) 
In-hospital mortality Young (97) 11 (4.7%) 
Elderly (30) 4 (8.9%)
pPCI, primary percutaneous coronary intervention.
* p = 0.001 vs. in younger patients for the same period.
£ p = 0.025 vs. in elderly patients for 1998–2001 period.
p non-signiﬁcant vs. in younger patients for the same period.
1 p non-signiﬁcant vs. in elderly patients for 1998–2001 period.no reperfusion treatment was chosen in 43.1% of the cases in
the elderly group (vs. 28.9% in younger patients, p < 0.001). The
use of pPCI as the reperfusion strategy was slightly lower in the
elderly group but with no statistical signiﬁcance (24.2% vs.
28.8%, p = 0.17). No signiﬁcant difference could be demonstrat-
ed in terms in reperfusion delays (either by thrombolysis or
pPCI) between the two sub-groups. In-hospital mortality rate
in the overall study population was at 9% and was signiﬁcantly
higher in the elderly group in comparison with younger
patients (14.2% vs. 8.1%, p = 0.005). When looking at temporal-hospital mortality for elderly and younger patients during
ing age category for the indicated study period.
2–2005 (n = 349) 2006–2009 (n = 382) 2010–2013 (n = 392)
76 (25.2%) 154 (48.4%) 95 (28.1%)
6 (12.5%) 24 (37.7%) 16 (29.6%),£
130 (43.2%) 60 (18.9%) 139 (41.1%)
14 (29.2%) 6 (9.4%) 15 (27.8%),1
26 (8.6%) 28 (8.8%) 33 (9.8%)
12 (25%)* 7 (10.9%) 7 (13%),1
Table 4 – Factors associated to in-hospital death in elderly patients in univariate analysis.
Surviving (n = 181) Dead (n = 30) p
Female gender 53 (29.3%) 14 (46.7%) 0.058
Hypertension 77 (42.5%) 15 (50%) 0.44
Diabetes mellitus 51 (28.2%) 13 (43.3%) 0.09
Obesity 9 (5%) 1 (3.3%) 0.69
History of CAD 17 (9.4%) 3 (10%) 0.31
History of heart failure 7 (3.9%) 1 (3.3%) 0.88
Heart failure on-admission 44 (24.3%) 19 (63.3%) <0.001
Anterior localization 77 (48.1%) 17 (58.6%) 0.29
Spontaneous ﬁbrinolysis 14 (7.7%) 1 (3.3%) 0.385
Conservative medical therapy 74 (40.9%) 17 (56.7%) 0.211
Thrombolysis 42 (23.2%) 5 (16.7%) 0.425
Symptoms to thrombolysis delay (h) 3.66  2.1 3.8  2.16 0.894
Primary PCI 43 (23.8%) 8 (26.7%) 0.581
Symptoms to pPCI delay (h) 5.15  4.84 4.63  2.92 0.769
Anemia 126 (79.7%) 19 (65.5%) 0.091
Renal failure on-admission 21 (11.6%) 11 (36.7%) <0.001
Hyperglycemia on-admission 50 (31.8%) 17 (58.6%) 0.006
Cardiogenic shock 5 (2.8%) 7 (23.3%) <0.001
New onset atrial ﬁbrillation 17 (9.4%) 8 (26.7%) 0.019
Atrioventricular block 24 (13.3%) 10 (33.3%) 0.006
Hemorrhage 5 (2.9%) 3 (10%) 0.063
Inotropic agents use 20 (11%) 22 (73.3%) <0.001
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reperfusion therapies (thrombolysis or pPCI) were numerically
more used in younger patients, and in-hospital mortality
remained numerically higher in the elderly subgroups except
for 2002–2005 period, where it reached statistical signiﬁcance.
When comparing the last (2010–2013) period to the early one
(1998–2001), no signiﬁcant difference could be reached in in-
hospital mortality and thrombolysis use between the two
periods. On the other hand, a signiﬁcant increase was noted in
pPCI use between the early and the last period (p = 0.025).
Factors associated to in-hospital death in the elderly group
were studied in univariate analysis (Table 4). When compared
to surviving patients (n = 181), those who died (n = 30) had
more frequently heart failure and renal failure on admission
(63.3% vs. 24.3%, p < 0.001 and 36.7% vs. 11.6%, p < 0.001,
respectively). In died patients, new-onset atrial ﬁbrillation and
atrioventricular block occurred more frequently in the hospital
course (26.7% vs. 9.4%, p = 0.019 and 33.3% vs. 13.3%, p = 0.006,
respectively). The recourse to inotropic agents during hospital
stay was more frequent in the elderly group (73.3% vs. 11%,
p < 0.001).
In multivariate analysis (Table 5), the only factors that were
independently associated with in-hospital death in elderly
patients were heart failure on-admission (OR = 3.24, 95% CI:
1.15–9.13, p = 0.026), renal failure on-admission (OR = 3.67, 95%Table 5 – Factors independently associated to in-hospital
death in elderly patients in multivariate analysis.
Variable Odds ratio 95% CI p
Hyperglycemia on-admission 2.67 0.97–7.38 0.057
Heart failure on-admission 3.2 1.15–9.13 0.026
Renal failure on-admission 3.6 1.11–12.11 0.033
Inotropic agents use 13.3 4.78–37.03 <0.001CI: 1.11–12.11, p = 0.033) and inotropic agents use (OR = 13.33,
95% CI: 4.78–37.03, p < 0.001).
4. Discussion
This study is, to our knowledge, the largest published series
addressing speciﬁcally the issue of STEMI in the elderly
population in Tunisia. Furthermore, it presents an actual
depiction of risk proﬁle, management strategies and in-
hospital prognosis of STEMI in this age group. Results are
issued from a ﬁfteen-year experience population and some of
them deserve careful consideration.
Male gender preponderance in STEMI patients is main-
tained over age categories even though less striking in the
elderly group. This ﬁnding is well explained by the difference
in the risk proﬁle between the two genders and is reported in
some Middle-Eastern and larger Western studies as well.5–8 In
our study, tobacco smoking as a risk factor is alarmingly
prevalent. Its prevalence remains higher than that reported in
other studies5,8 and mandate speciﬁc intervention at the
population scale. Other traditional coronary risk factors are
more prevalent in the elderly group except for obesity, which
was less frequent in this group.
As reported in other studies,3,9 in our study, elderly patients
presenting for STEMI are more likely to have HF upon
presentation. This fact is obviously related to a higher
prevalence of other HF risk factors in the elderly population
such as hypertension. Likewise, elderly patients are more
likely to have multivessel disease in the setting of ACS in
general, a factor that is highly associated to HF in CAD both in
the acute and chronic settings.10
Similar to that reported in others, in the present study,
elderly people presenting for STEMI are more likely to be
managed conservatively (i.e. with no reperfusion therapy) in
comparison to younger patients. That is well accounted for by
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tion and a slight trend, although not statistically signiﬁcant to
less pPCI implementation. Reperfusion strategies for STEMI
had been addressed in some Middle-Eastern reports.11,12 In the
Gulf RACE registry,11 among 8176 enrolled ACS patients, 3202
(39%) presented with STEMI; only 1584 (19%) patients under-
went coronary angiography during the index hospitalization
and age category failed to stand out as an independent
predictor of coronary angiography use in multivariate analy-
sis. More recently, in a 20-year analysis carried-out in Qatar,
Ahmed et al.12 reported a trend to a lesser use of thrombolysis
as the reperfusion option for STEMI in the last two decades.
Contrarily, pPCI prevalence increased from 2.5% to 14.6% of the
overall study population and an age >70 years arose as an
independent predictor of in-hospital death. These rates are
lower than those noticed in our study, where even for patients
older than 75 years, pPCI was used in nearly the quarter of the
cases. In the large European Euroheart Acute Coronary
Syndrome survey,3 pPCI was not the preferred reperfusion
therapy in patients presenting with acute STEMI across the
whole age spectrum, and a reperfusion therapy (pPCI or
thrombolysis) was implemented in less than 20% of patients
aged 75 years or more. More recently in the British Myocardial
Ischemia National Audit Project (MINAP),8 pPCI use in the very
elderly (≥85 years) rose from 0.5% in 2003–2004 to 32.2% in
2009–2010, and use of in-hospital thrombolysis in the elderly
(≥75 years) was remarkably frequent (≥50% either in men or
women).
In the present study, in-hospital prognosis in elderly
patients presenting with STEMI remains poor and in-hospital
mortality rate is signiﬁcantly higher than in younger patients.
In-hospital mortality rates in patients presenting with STEMI
were reported in several Middle-Eastern studies but no speciﬁc
data for the elderly are available. Ahmed et al. reported a 3.6
fold higher mortality rate in patients older than 70 years when
compared to those who were 50 or younger,12 whereas in
Western reports, in-hospital mortality rate across the whole
age spectrum remains quite low. For example, in Scandinavian
countries, where pPCI program is well established and high
standards of care is applied, 30-days mortality rates in old and
very old patients managed invasively was around 3%.13,14
Prognosis improvement in STEMI patients in Europe could be
explained by the introduction of new medications in ACS
improvement in clinical management in general and in the
setting of pPCI in particular as well as early invasive
management strategy speciﬁcally in the elderly population.1,15
Another explanation for the worse prognosis in STEMI patients
in the present study, when compared to Western studies is the
remarkable difference in cardiovascular risk proﬁle in old
Tunisian patients: prevalence of classic cardiovascular risk
factors such as diabetes mellitus and hypertension in the
study population is signiﬁcantly higher than that reported in
major Western series.14,16,17
4.1. Study limitations
This is a retrospective observational study in one Tunisian
tertiary care center. Although depicting a somewhat realistic
picture of STEMI management and prognosis in the elderly,
data are issued from an urban population with a relativelywesternized lifestyle for many of the patients enrolled. These
data could not be generalized to the overall Tunisian
population neither to the whole North African countries, in
particular because of an important rural population in this part
of the world. Contemporary therapeutic strategies are imple-
mented only in regions beneﬁtting from tertiary health care
facilities and prognosis of old patients presenting for STEMI in
far-off primary care centers with no reperfusion therapeutic
option could be quite different. Likewise, the small sample size
in the elderly group accounts for the lack of statistical
relationship between some factors (reperfusion therapeutics,
in-hospital complication) and in-hospital death. Also, the lack
of precise information about all the medications at discharge
taken by elderly and younger patients makes it difﬁcult to
interpret long-term outcomes in the two sub-groups. Finally,
multicenter studies have to be conducted to better describe
regional management and prognostic particularities and
adjust intervention strategies at a nationwide scale.
5. Conclusions
In this single center Tunisian registry, elderly patients
presenting with STEMI have a higher prevalence of cardiovas-
cular risk factors in comparison to younger patients. Manage-
ment strategies were different between the two groups with
less recourse to reperfusion therapy in the elderly group. In-
hospital prognosis was poor in elderly. Heart failure and renal
failure on-admission as well as inotropic agents use were
highly predictive of in-hospital death.
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